# clm_684F3B3B6CFA

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_revenue  
value: 12,728,500,000 United States dollar  
valid_from: 2025-03-31  
valid_to: 2025-06-30  
published: 2025-05-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_7CBD9D7BE5AE  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly revenue: 12,728,500,000 United States dollar", as of 2025-03-31 (until 2025-06-30). Claim clm_684F3B3B6CFA, https://asof.is/claim/clm_684F3B3B6CFA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/0000059478-25-000132-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-Q Q1 FY2025, filed 2025-05-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/0000059478-25-000132-index.htm (primary, SEC EDGAR 10-Q Q1 FY2025, published 2025-05-01)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_revenue | 11,439,100,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_684F3B3B6CFA](/claim/clm_684F3B3B6CFA.md) | [clm_0D9BE0B6BA02](/claim/clm_0D9BE0B6BA02.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.